Expression and prognostic significance of iNOS in uveal melanoma
Open Access
- 23 March 2010
- journal article
- early detection-and-diagnosis
- Published by Wiley in International Journal of Cancer
- Vol. 126 (11) , 2682-2689
Abstract
Uveal melanoma (UM) is the most common primary intraocular tumor in adults. Disease metastasis occurs in half of the patients and is uniformly fatal despite systemic therapy. Inducible nitric oxide synthase (iNOS) is associated with disease progression in various malignancies including cutaneous melanoma. In this retrospective cohort, we examined the prognostic value of iNOS in UM by performing immunohistochemistry on paraffin‐embedded sections of primary tumors (90 patients) and matched primary and metastatic hepatic tumors (19 patients) with complete histopathological and clinical data. We show that iNOS is expressed in UM (57% of the patients) and high iNOS levels significantly (p = 0.04; hazard ratio (HR) = 2.3) predict disease‐specific survival (DSS) as assessed by Kaplan‐Meier analysis and univariate Cox's proportional hazards regression model. Furthermore, high iNOS expression in the UM primary tissue was significantly associated with metastatic disease and vice versa. Expression of iNOS in hepatic metastases significantly (p = 0.02) predicted a shortened survival as assessed by Kaplan‐Meier analysis. However, iNOS did not appear to be a significant (p = 0.16; HR = 1.9) factor in the multivariate Cox's regression analysis performed together with the clinical parameters tumor diameter, tumor cell type, and tumor location in which only tumor diameter predicted DSS. In conclusion, iNOS predicts DSS in UM and may play a role in disease progression but it is not an independent prognostic factor.Keywords
This publication has 31 references indexed in Scilit:
- Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanomaCancer Immunology, Immunotherapy, 2008
- Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosisNitric Oxide, 2008
- Expression of COX-2 and Prognostic Outcome in Uveal MelanomaCurrent Eye Research, 2008
- Variates of Survival in Metastatic Uveal MelanomaJournal of Clinical Oncology, 2005
- Nitric oxide signaling in colon cancer chemopreventionMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
- Survival rates with uveal melanoma in the United States: 1973–1997Ophthalmology, 2003
- α‐MSH and the Regulation of Melanocyte FunctionAnnals of the New York Academy of Sciences, 1999
- The prevalence and location of metastases from ocular melanoma: imaging study in 110 patients.American Journal of Roentgenology, 1991
- Synthesis of nitric oxide from L-arginine: a recently discovered pathway induced by cytokines with antitumour and antimicrobial activityResearch in Immunology, 1991
- Nitric oxide: A cytotoxic activated macrophage effector moleculeBiochemical and Biophysical Research Communications, 1988